Levine Cancer Institute - Cleveland — Shelby, North Carolina

Levine Cancer Institute - Cleveland is a clinical research site located in Shelby, North Carolina, United States 28150.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Levine Cancer Institute - Cleveland has participated in 1 clinical trials.

Therapeutic areas: Pancreatic Cancer.

Sponsors: Wake Forest University Health Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Shelby

Browse all research sites in North Carolina · View every site in Shelby

• Atrium Health Cleveland/LCI-Cleveland
• Carolina Research Center
• GSK Investigational Site
• Novartis Investigative Site
• CORE
• Cleveland Hematology and Oncology Associates PC
• Research Site
• Vita Eye Clinic
• Shelby Clinical Research
• Novo Nordisk Investigational Site
• Carolinas HealthCare System Cleveland
• CYS-005 Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Levine Cancer Institute - Cleveland?

Levine Cancer Institute - Cleveland has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Levine Cancer Institute - Cleveland conducted?

Levine Cancer Institute - Cleveland has 1 clinical trials on record. Their work covers Pancreatic Cancer.

Is Levine Cancer Institute - Cleveland accredited by Crixeo Clinical Trials?

Levine Cancer Institute - Cleveland has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Levine Cancer Institute - Cleveland?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.